Table 1.
Demographic characteristics of REDUCE participants according to the presence of chronic and acute prostate inflammation at baseline
| Chronic prostatic inflammation | Acute prostatic inflammation | |||||
|---|---|---|---|---|---|---|
| Absent | Present | Absent | Present | |||
| N=1,504 (23%) |
N=5,151 (77%) |
p value | N=5,650 (85%) |
N=1,005 (15%) |
p value | |
| Age, mean (SD) | 62.2 (6.1) | 62.8 (6.0) | 0.0006 | 62.8 (6.0) | 62.1 (6.1) | 0.0002 |
| Race, n (%) | ||||||
| White | 1,400 (93) | 4,698 (91) | 0.021 | 5,177 (92) | 921 (92) | 0.989 |
| Non-white | 104 (7) | 453 (9) | 473 (8) | 84 (8) | ||
| Region, n (%) | ||||||
| N. America | 336 (22) | 1,562 (30) | <0.0001 | 1,496 (26) | 402 (40) | <0.0001 |
| Europe | 990 (66) | 2,947 (57) | 3,405 (60) | 532 (53) | ||
| Other | 178 (12) | 642 (12) | 749 (13) | 71 (7) | ||
| BMI (kg/m2), median (IQR) | 26.8 (24.8–29.0) | 26.9 (24.9–29.4) | 0.277 | 26.9 (24.9–29.4) | 26.9 (24.8–29.3) | 0.766 |
| Diabetes, n (%) | ||||||
| No | 1,369 (91) | 4,726 (92) | 0.373 | 5,174 (92) | 921 (92) | 0.944 |
| Yes | 135 (9) | 425 (8) | 476 (8) | 84 (8) | ||
| Statin use, n (%) | ||||||
| No | 1,212 (81) | 4,226 (82) | 0.198 | 4,632 (82) | 806 (80) | 0.178 |
| Yes | 292 (19) | 925 (18) | 1,018 (18) | 199 (20) | ||
| NSAID use, n (%) | ||||||
| No | 1,075 (71) | 3,629 (70) | 0.443 | 4,011 (71) | 693 (69) | 0.191 |
| Yes | 429 (29) | 1,522 (30) | 1,639 (29) | 312 (31) | ||
| Alcohol use, n (%) | ||||||
| None | 360 (24) | 1,372 (27) | 0.040 | 1,472 (26) | 260 (26) | 0.693 |
| Moderate | 720 (48) | 2,463 (48) | 2,692 (48) | 491 (49) | ||
| Heavy | 417 (28) | 1,292 (25) | 1,461 (26) | 248 (25) | ||
| Smoking status, n (%) | ||||||
| Never | 698 (46) | 2,321 (45) | 0.124 | 2,580 (46) | 439 (44) | 0.001 |
| Former | 604 (40) | 2,028 (39) | 2,257 (40) | 375 (37) | ||
| Current | 202 (13) | 802 (16) | 813 (14) | 191 (19) | ||
*
data for alcohol use was missing for n=31 participants